Turning Point Brands stock soars to all-time high of $81.14

Turning Point Brands Inc (NYSE:TPB) stock has reached an unprecedented peak, touching an all-time high of $81.14. According to InvestingPro data, the company maintains a strong financial health rating of GOOD, with impressive gross profit margins of 55% and liquid assets exceeding short-term obligations. This milestone underscores a period of robust growth for the company, which has seen its stock value surge by an impressive 136.7% over the past year, supported by strong revenue growth of 24.5%. Investors have rallied behind TPB’s strong performance, propelling the stock to new heights and reflecting a significant vote of confidence in the company’s market position and future prospects. The achievement of this all-time high represents a key moment for Turning Point Brands as it continues to navigate the competitive landscape and seeks to maintain its upward trajectory. Based on current metrics, analysts maintain a bullish outlook with price targets ranging from $85 to $95. Discover more insights and 12 additional ProTips for TPB with an InvestingPro subscription.

In other recent news, Turning Point Brands reported impressive financial results for the first quarter of 2025, surpassing both earnings and revenue forecasts. The company achieved earnings per share of $0.91, beating the expected $0.71, and reported revenue of $106.4 million, exceeding the forecast of $92.53 million. This performance marks a 28% year-over-year increase in revenue, driven by significant growth in the Modern Oral segment. Adjusted EBITDA also rose by 12% compared to the previous year. Additionally, at the company’s annual meeting, shareholders approved several key decisions, including the election of directors and the ratification of KPMG LLP as the independent accountant.

Moreover, the meeting resulted in an amendment to limit officer liability, reflecting shareholder confidence in the company’s leadership. In terms of strategic initiatives, Turning Point Brands is focusing on expanding its Modern Oral and Zig Zag segments. The company projects an adjusted EBITDA of $108-113 million for the remainder of 2025, with anticipated tariff impacts and a budgeted capital expenditure. These developments indicate a strong operational performance and effective execution of strategic initiatives.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.